NCT06216184 is a clinical trial of Vortexing in Catheter-related Bloodstream Infection, sponsored by University Hospital of Canary Islands.

Who is sponsoring NCT06216184?

NCT06216184 is sponsored by University Hospital of Canary Islands.

What drugs are being tested in NCT06216184?

Interventions in NCT06216184: Vortexing.

What condition does NCT06216184 study?

NCT06216184 studies Catheter-related Bloodstream Infection.

Is NCT06216184 still recruiting?

NCT06216184 is currently completed. Last updated 22 January 2024.

Last reviewed 2024-01-22 · How we verify

NCT06216184

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adding Vortexing to the Maki Technique Provides no Benefit for the Diagnosis of Catheter-related Bacteremia

Completed Last updated 22 January 2024

What this trial tests

trial testing Vortexing in Catheter-related Bloodstream Infection in 136 participants. Completed in 30 September 2022.

Timeline

1 April 2022

Primary endpoint
30 September 2022

30 September 2022

Quick facts

Lead sponsor	University Hospital of Canary Islands
Status	Completed
Study type	OBSERVATIONAL
Enrollment	136
Start date	1 April 2022
Primary completion	30 September 2022
Estimated completion	30 September 2022
Sites	1 location across Spain

Drugs / interventions tested

Vortexing

Conditions studied

Catheter-related Bloodstream Infection — all drugs for Catheter-related Bloodstream Infection →

Sponsor

University Hospital of Canary Islands

Who can join

Eligibility, any sex, with Catheter-related Bloodstream Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators wanted to determine whether the combined use of vortexing and Maki techniques provides profitability versus the Maki technique for the diagnosis of catheter tip colonization and catheter-related bloodstream infection

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Adding vortexing to the Maki technique provides no benefit for the diagnosis of catheter colonization or catheter-related bacteremia.
Lorente L, Lecuona Fernandez M, González-Mesa A, Oliveras-Roura J, et al · · 2024 · PMID 38633472 · DOI 10.5492/wjccm.v13.i1.89085

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06216184 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital of Canary Islands
Last refreshed: 22 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06216184.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing